RE:RE:RE:Rock-bottom prices ahead? Not sure how many actually read the Q3 newsletter - seemingly deemed a non-event - but in it the Company set out a sequence of milestones at the end of which (scheduled to be at this time next year or shortly before) they intend to treat humans afflicted by GBM and NSCLC with low-dose x-ray from outside the body in an attempt to destroy their cancers - this being founded on highly promising pre-clinical results:
https://theralase.com/theralase-lead-anti-cancer-drug-effective-in-the-destruction-of-brain-cancer-when-activated-by-x-rays/
https://money.tmx.com/en/quote/TLT/news/7284245847456984/Theralase_Granted_United_States_Patent_to_Destroy_Cancer_Cells_with_XRay_Activated_Photo_Dynamic_Compounds
If Merck or Pfizer had announced this their market cap would have soared by billions of dollars.The reaction for TLT was that the stock touched an historic low of 13 cents yesterday - equating to a market cap of around 27m CAD.
Continue to accumulate at these levels but with an absolute conviction as to the integrity of the science.This is the only reason for being here - as has been said so many times it will all come down to the Clinic.